Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Merker

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Journal of Neuro-Oncology|February 10, 2015
Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literatureAna-Maria Vranceanu, Vanessa L Merker, Elyse R Park, et al.
Journal of Neuro-Oncology|July 16, 2014
The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot studyAna-Maria Vranceanu, Vanessa L Merker, Scott R Plotkin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 17, 2013
Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patientsScott R Plotkin, Vanessa L Merker, Alona Muzikansky, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|January 9, 2023
Indicators of health in Down syndrome: A virtual focus group study with patients and their parentsStephanie L Santoro, Maria J Cabrera, Kelsey Haugen, et al.
Medical Care|November 8, 2024
Using Well-Being Measurements to Enhance Clinical Practice: Why and How to Ask Patients About Their Broader Well-BeingDawne Vogt, Shelby Borowski, Bella Etingen, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 25, 2000
Impact of antenatal corticosteroid therapy in very low birth weight infants on chronic lung disease and other morbidities of prematurityL R Wells, L A Papile, M O Gardner, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2014
Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patientsKatherine M Slusarz, Vanessa L Merker, Alona Muzikansky, et al.
Biology of the Neonate|August 14, 1998
Positive relationship of cortisol concentrations and oral nutrition to epidermal growth factor concentrations in preterm infantsS M Scott, K Watterberg, C Rogers, et al.
The Oncologist|August 29, 2012
Clinical features of schwannomatosis: a retrospective analysis of 87 patientsVanessa L Merker, Sonia Esparza, Miriam J Smith, et al.
Neurology|July 7, 2021
Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical TrialsHeather L Thompson, Ann Blanton, Barbara Franklin, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Journal of Neuro-Oncology|February 10, 2015
Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literatureAna-Maria Vranceanu, Vanessa L Merker, Elyse R Park, et al.
Journal of Neuro-Oncology|July 16, 2014
The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot studyAna-Maria Vranceanu, Vanessa L Merker, Scott R Plotkin, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 17, 2013
Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patientsScott R Plotkin, Vanessa L Merker, Alona Muzikansky, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|January 9, 2023
Indicators of health in Down syndrome: A virtual focus group study with patients and their parentsStephanie L Santoro, Maria J Cabrera, Kelsey Haugen, et al.
Medical Care|November 8, 2024
Using Well-Being Measurements to Enhance Clinical Practice: Why and How to Ask Patients About Their Broader Well-BeingDawne Vogt, Shelby Borowski, Bella Etingen, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 25, 2000
Impact of antenatal corticosteroid therapy in very low birth weight infants on chronic lung disease and other morbidities of prematurityL R Wells, L A Papile, M O Gardner, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2014
Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patientsKatherine M Slusarz, Vanessa L Merker, Alona Muzikansky, et al.
Biology of the Neonate|August 14, 1998
Positive relationship of cortisol concentrations and oral nutrition to epidermal growth factor concentrations in preterm infantsS M Scott, K Watterberg, C Rogers, et al.
The Oncologist|August 29, 2012
Clinical features of schwannomatosis: a retrospective analysis of 87 patientsVanessa L Merker, Sonia Esparza, Miriam J Smith, et al.
Neurology|July 7, 2021
Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical TrialsHeather L Thompson, Ann Blanton, Barbara Franklin, et al.
Pageof 8